CRC (COLORECTAL CANCER)
Clinical trials for CRC (COLORECTAL CANCER) explained in plain language.
Never miss a new study
Get alerted when new CRC (COLORECTAL CANCER) trials appear
Sign up with your email to follow new studies for CRC (COLORECTAL CANCER), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets common Cancer-Causing mutation in major trial
Disease control Not yet recruitingThis study is testing a new drug called GFH276 in adults with advanced cancers that have a specific genetic change called a RAS mutation. The main goals are to find a safe dose and see if the drug can shrink tumors in cancers like pancreatic, lung, and colorectal cancer. It is an…
Matched conditions: CRC (COLORECTAL CANCER)
Phase: PHASE1, PHASE2 • Sponsor: Genfleet Therapeutics (Shanghai) Inc. • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
Texts & telehealth aim to close colon cancer gap for native americans
Prevention Not yet recruitingThis study aims to help more Native Americans in Oklahoma get a needed follow-up colonoscopy after an abnormal at-home stool test. Researchers will work with the community to create culturally sensitive text messages and videos, and test if offering a telehealth pre-visit instead…
Matched conditions: CRC (COLORECTAL CANCER)
Phase: NA • Sponsor: University of Oklahoma • Aim: Prevention
Last updated Mar 30, 2026 14:33 UTC